三年COVID-19疫苗接种管理揭示的疫苗注射相关肩部损伤(SIRVA)发生率
基于Eudravigilance数据库的回顾性研究分析了2020年1月至2022年12月间COVID-19疫苗报告,在1,172,583,008剂接种中43,192例符合SAEFVIC的SIRVA定义,发生率为每10万剂3.7例;女性占33,828例(77.9%),部分疫苗制剂发生率更高。
要点
- 三年间COVID-19疫苗接种中SIRVA发生率为每10万剂3.7例,高于既往报告。
- 女性受影响不成比例,33,828例(77.9%)为女性。
- 某些COVID-19疫苗制剂的发生率高于其他制剂。
核心结论
- 本研究报告的SIRVA发生率高于既往报告,女性受影响多于男性,且某些疫苗制剂可能与更高的SIRVA发生率相关,SIRVA的成因可能是多方面的。
研究设计与样本
- 对公开可用的Eudravigilance数据库(药物警戒数据)进行回顾性研究,检查2020年1月至2022年12月间所有COVID-19疫苗病例报告,分析其是否符合SAEFVIC的SIRVA定义和纳入标准。
主要发现
- 2020年1月至2022年12月间,从1,172,583,008剂接种的COVID-19疫苗中,43,192例符合SAEFVIC的SIRVA纳入标准,等于三年间每10万剂接种3.7例的发生率。
- 女性受试者受影响不成比例,为33,828例(77.9%)。
- 某些COVID-19疫苗制剂的发生率高于其他制剂。
关键数值与推荐
- SIRVA发生率:每10万剂接种3.7例(基于1,172,583,008剂接种中43,192例符合SAEFVIC纳入标准)。
- 女性病例数:33,828例(77.9%)。
局限性
- 既往关于SIRVA的证据主要限于病例研究和病例系列,发生率仍未知。
- 当前对SIRVA成因的理解进一步受到定义和报告要求不明确的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shoulder injury related to vaccine administration (SIRVA) has been reported to be a rare but real complication of vaccination. It is considered attributable to an incorrect vaccine administration technique by the vaccinator. To date, evidence about SIRVA is mainly limited to case studies and case series, and the incidence remains unknown. This study aimed to determine the incidence of SIRVA. METHODS: We conducted a retrospective study of the publicly available Eudravigilance database (pharmacovigilance data). We examined all COVID-19 vaccine case reports administered between January 2020 and December 2022. Reports were analysed to see if they met the Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC) definition and inclusion criteria for SIRVA. Data was extracted. FINDINGS: Between January 2020, and December 2022, from 1,172,583,008 administered COVID-19 vaccines, 43,192 cases met the SAEFVIC inclusion criteria for SIRVA. This equals an incidence of 3·7 cases per 100,000 vaccines administered during the three years. Female subjects are disproportionately affected, with 33,828 cases (77.9 %). The incidence was higher with some COVID-19 vaccine formulations than others. INTERPRETATION: The incidence found in this study is higher than previously reported. The data also reflects that it affects more female subjects than males. While previously considered avoidable using the correct vaccine administration technique, the data challenges this notion as it shows that certain vaccine formulations may be associated with a higher incidence of the condition. The causes of SIRVA are likely multifaceted, with current understanding being further impacted by unclear definitions and reporting requirements. FUNDING: This project was supported by an ECARD grant from The University of Canberra.
引用
- Mackenzie LJ, Bousie JA, Newman P, et al. What three years of COVID-19 vaccine administration reveals about the incidence of shoulder injury related to vaccine administration (SIRVA). Vaccine. 2025. PMID: 39983541. doi:10.1016/j.vaccine.2025.126892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。